🇺🇸 FDA
Patent

US 10639320

Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis

granted A61KA61K31/28A61K31/7135

Quick answer

US patent 10639320 (Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis) held by KOREA UNITED PHARM. INC. expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KOREA UNITED PHARM. INC.
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/28, A61K31/7135, A61K33/242, A61P